Insider Trading June 24, 2026 05:12 PM

Quantumscape CFO Executes Stock Sale Under Pre-Arranged Trading Plan

Kevin Hettrich's transaction follows recent earnings beat and expanded Honda collaboration, though shares trade below sale price amid solid-state battery development.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
QS

Kevin Hettrich, Chief Financial Officer of QuantumScape Corp (NYSE: QS), executed a sale of 9,800 shares of the company’s Class A Common Stock on June 22, 2026, totaling $77,811 under a Rule 10b5-1 trading plan adopted on June 11, 2025. The weighted average sale price was $7.9399 per share, with individual prices ranging from $7.585 to $8.435. Following the transaction, Hettrich directly holds 1,826,057 shares, including 1,955 acquired through the Employee Stock Purchase Plan on June 1, 2026, and 1,356,436 restricted stock units (RSUs) and performance restricted stock units (PSUs) subject to vesting milestones. QuantumScape recently reported Q1 2026 earnings of -0.16 per share, beating estimates of -0.18 by 11.11%, and announced a joint research agreement with Honda R&D Co., Ltd. on solid-state battery development. The stock currently trades at $7.14, below the CFO’s sale price, despite a 71% return over the past year and a market capitalization of $4.36 billion.

Quantumscape CFO Executes Stock Sale Under Pre-Arranged Trading Plan
QS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Kevin Hettrich executed a $77,811 stock sale under a pre-established Rule 10b5-1 plan, maintaining significant equity exposure through direct holdings and RSUs/PSUs.
  • QuantumScape reported Q1 2026 EPS of -0.16, beating estimates of -0.18 by 11.11%, while advancing solid-state battery technology through a multi-year partnership with Honda R&D Co., Ltd.
  • Shares currently trade at $7.14, below the CFO’s sale price, despite a 71% annual return and a $4.36 billion market capitalization.

San Jose, CA – Kevin Hettrich, serving as Chief Financial Officer for QuantumScape Corp (NYSE: QS), completed the sale of 9,800 shares of the company’s Class A Common Stock on June 22, 2026. The transaction generated proceeds of $77,811. The shares were divested at a weighted average price of $7.9399 per share, with individual transaction prices varying between $7.585 and $8.435. The sale was conducted under a Rule 10b5-1 trading plan that Mr. Hettrich established on June 11, 2025.

The timing of this executive sale occurs against a backdrop of recent corporate developments. QuantumScape reported first quarter 2026 earnings that surpassed analyst expectations, posting an earnings per share (EPS) of -0.16 compared to the anticipated -0.18. This result exceeded forecasts by 11.11%, indicating a positive reception from market participants. Additionally, the company announced a joint research agreement with Honda R&D Co., Ltd., targeting the development and manufacturing processes of solid-state batteries. This multi-year program follows Honda’s completion of a technology evaluation agreement, which encompassed a thorough technical study of QuantumScape’s solid-state platform. The collaboration aims to advance battery technology through competitive benchmarking and testing.

Following these transactions, Mr. Hettrich directly holds 1,826,057 shares of QuantumScape Class A Common Stock. This total includes 1,955 shares acquired through the company’s Employee Stock Purchase Plan on June 1, 2026. His holdings also comprise 1,356,436 shares represented by restricted stock units (RSUs) and performance restricted stock units (PSUs), which entitle him to receive one share of Class A Common Stock for each unit upon vesting, subject to continued service and achievement of certain performance milestones.

QuantumScape shares have delivered a strong 71% return over the past year, though the stock currently trades at $7.14, below the CFO’s sale price. According to InvestingPro analysis, the stock remains close to its Fair Value, with the company maintaining a market capitalization of $4.36 billion. The stock’s recent performance reflects ongoing strategic partnerships and financial metrics that continue to draw attention in the market.

Key Points:

  • Kevin Hettrich executed a $77,811 stock sale under a pre-established Rule 10b5-1 plan, maintaining significant equity exposure through direct holdings and RSUs/PSUs.
  • QuantumScape reported Q1 2026 EPS of -0.16, beating estimates of -0.18 by 11.11%, while advancing solid-state battery technology through a multi-year partnership with Honda R&D Co., Ltd.
  • Shares currently trade at $7.14, below the CFO’s sale price, despite a 71% annual return and a $4.36 billion market capitalization.

Risks and Uncertainties:

  • The stock trades below the CFO’s sale price of $7.9399 weighted average, indicating potential valuation pressure despite recent earnings beats and strategic partnerships.
  • QuantumScape’s ongoing losses, reflected in a Q1 2026 EPS of -0.16, highlight continued financial challenges in the solid-state battery development sector.
  • The success of the Honda collaboration depends on achieving performance milestones and technical benchmarks, introducing execution risk in the competitive battery technology market.

Risks

  • The stock trades below the CFO’s sale price of $7.9399 weighted average, indicating potential valuation pressure despite recent earnings beats and strategic partnerships.
  • QuantumScape’s ongoing losses, reflected in a Q1 2026 EPS of -0.16, highlight continued financial challenges in the solid-state battery development sector.
  • The success of the Honda collaboration depends on achieving performance milestones and technical benchmarks, introducing execution risk in the competitive battery technology market.

More from Insider Trading

Executive Capital Commitment at Bed Bath & Beyond Aug 6, 2026 EXLService President Vikas Bhalla Executes $384,890 Share Sale Under Pre-Existing Trading Plan Aug 6, 2026 Arcutis Biotherapeutics Executive Divests Shares Amid Strong Financial Backdrop Aug 6, 2026 Executive Capital Deployment and Leadership Restructuring at Hanover Bancorp Aug 3, 2026 Adaptive Biotechnologies Executive Liquidates Shares as Volume Metrics Diverge From Profitability Aug 3, 2026